Translate Bio, Sanofi COVID-19 vaccine candidate produces immune response in animal studies


Aug 25 (Reuters) - Translate Bio Inc TBIO.O said on Tuesday that an experimental coronavirus vaccine it developed with French drugmaker Sanofi SA SASY.PA induced immune response in early-stage non-human primate studies.

In a regulatory filing, the company cited Sanofi's presentation slides showing that the vaccine candidate induced neutralizing antibodies and T-cell responses in animal studies.

(Reporting by Manojna Maddipatla in Bengaluru; Editing by Maju Samuel)

((manojna.kalyani@thomsonreuters.com; +91 8061822700;))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


More Related Articles

Info icon

This data feed is not available at this time.

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.